Solventum, Minnesota’s newest Fortune 500 company, is finding its footing after starting its first full year of operations on shakier ground. The 3M spinoff commenced 2025 with a deflated stock, which ...

Solventum, the recently spun off healthcare arm of 3M, faces challenges in value creation due to stagnant growth, heavy debt burden, and entanglement with its former parent. The company's revenue ...

Business: Solventum, formerly known as 3M Health Care, is a global health-care company that was spun out from 3M on April 1. It has four main segments. First, there is Medical Surgical, a provider of ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why Solventum is on investors’ radar today Solventum (SOLV) is attracting fresh ...

6 analysts have shared their evaluations of Solventum (NYSE:SOLV) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick overview of ...

Shares of Solventum rose Tuesday after the company agreed to sell its filtration and purification business to medical device maker Thermo Fisher Scientific for $4.1 billion. Solventum Chief Executive ...

Trian Fund Management, which beneficially owns ~5% of Solventum Corporation (SOLV) and is the company’s largest active shareholder, released an open letter and slide deck outlining its views on ...

Analysts are changing their tune on Solventum as 2025 comes to a close, as analysts at BTIG upgrade the company to “buy” in the final month of the year. Solventum has spent the last year routinely ...